MetLife Investment Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $449K | Sell |
|
|||||
|
2025
Q1 | $184K | Hold |
|
|||||
|
2024
Q4 | $227K | Hold |
|
|||||
|
2024
Q3 | $194K | Hold |
|
|||||
|
2024
Q2 | $196K | Buy |
|
|||||
|
2024
Q1 | $455K | Buy |
|
|||||
|
2023
Q4 | $377K | Hold |
|
|||||
|
2023
Q3 | $359K | Hold |
|
|||||
|
2023
Q2 | $507K | Buy |
|
|||||
|
2023
Q1 | $356K | Hold |
|
|||||
|
2022
Q4 | $478K | Hold |
|
|||||
|
2022
Q3 | $848K | Buy |
|
|||||
|
2022
Q2 | $320K | Hold |
|
|||||
|
2022
Q1 | $478K | Buy |
|
|||||
|
2021
Q4 | $214K | Hold |
|
|||||
|
2021
Q3 | $273K | Buy |
|